SpectraScience (SCIE) Targets Colorectal Cancer

SpectraScience Inc. (OTCBB: SCIE) is a designer, developer and manufacturer of light-based analysis systems capable of determining whether tissue is normal, precancerous or cancerous without removing physical tissue from the body. The company has developed a promising technology that delivers clear cancer biopsy results in real-time, initially targeting the colorectal cancer industry, alongside companies like